Transepithelial Iontophoresis-Assisted Cross Linking for Progressive Keratoconus: Up to 7 Years of Follow Up.

Riccardo Vinciguerra Emanuela Filomena LegrottaglieCostanza TrediciCosimo MazzottaPietro RosettaPaolo Vinciguerra

Published in: Journal of clinical medicine (2022)

Our study shows the ability of I-CXL to slow down KC progression in the majority of included patients, improving high order and comatic aberrations. A 26% progression rate was reported.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
copy number
patient reported